Neoatherosclerosis development following bioresorbable vascular scaffold implantation in diabetic and non-diabetic swine

نویسندگان

  • Nienke S. van Ditzhuijzen
  • Mie Kurata
  • Mieke van den Heuvel
  • Oana Sorop
  • Richard W. B. van Duin
  • Ilona Krabbendam-Peters
  • Jurgen Ligthart
  • Karen Witberg
  • Magdalena Murawska
  • Brett Bouma
  • Martin Villiger
  • Hector M. Garcia-Garcia
  • Patrick W. Serruys
  • Felix Zijlstra
  • Gijs van Soest
  • Dirk-Jan Duncker
  • Evelyn Regar
  • Heleen M. M. van Beusekom
چکیده

BACKGROUND DM remains a risk factor for poor outcome after stent-implantation, but little is known if and how DM affects the vascular response to BVS. AIM The aim of our study was to examine coronary responses to bioresorbable vascular scaffolds (BVS) in swine with and without diabetes mellitus fed a 'fast-food' diet (FF-DM and FF-NDM, respectively) by sequential optical coherence tomography (OCT)-imaging and histology. METHODS Fifteen male swine were evaluated. Eight received streptozotocin-injection to induce DM. After 9 months (M), 32 single BVS were implanted in epicardial arteries with a stent to artery (S/A)-ratio of 1.1:1 under quantitative coronary angiography (QCA) and OCT guidance. Lumen, scaffold, neointimal coverage and composition were assessed by QCA, OCT and near-infrared spectroscopy (NIRS) pre- and/or post-procedure, at 3M and 6M. Additionally, polarization-sensitive (PS)-OCT was performed in 7 swine at 6M. After sacrifice at 3M and 6M, histology and polymer degradation analysis were performed. RESULTS Late lumen loss was high (~60%) within the first 3M after BVS-implantation (P<0.01 FF-DM vs. FF-NDM) and stabilized between 3M and 6M (<5% change in FF-DM, ~10% in FF-NDM; P>0.20). Neointimal coverage was highly heterogeneous in all swine (DM vs. NDM P>0.05), with focal lipid accumulation, irregular collagen distribution and neointimal calcification. Likewise, polymer mass loss was low (~2% at 3M, ~5% at 6M;P>0.20) and not associated with DM or inflammation. CONCLUSION Scaffold coverage showed signs of neo-atherosclerosis in all FF-DM and FF-NDM swine, scaffold polymer was preserved and the vascular response to BVS was not influenced by diabetes.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Bioresorbable Scaffold: The Emerging Reality and Future Directions.

In the era of drug-eluting stents, large-scale randomized trials and all-comer registries have shown excellent clinical results. However, even the latest-generation drug-eluting stent has not managed to address all the limitations of permanent metallic coronary stents, such as the risks of target lesion revascularization, neoatherosclerosis, preclusion of late lumen enlargement, and the lack of...

متن کامل

Bioresorbable vascular scaffold: promises and the fallen child-as-king?

Correspondence to Stéphane Cook; [email protected] THE BIORESORBABLE VASCULAR SCAFFOLDS ‘BVS’ The main limitation of percutaneous coronary intervention compared to open-heart surgery is the insertion of a foreign body (usually a stent) inside the coronary artery. This is associated with foreign body inflammation that triggers restenosis, neoatherosclerosis and late-occurring stent thrombos...

متن کامل

Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus: Results of the Absorb Diabetic Substudy.

OBJECTIVES The study sought to evaluate the efficacy and safety of the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS) (Abbott Vascular, Abbott Park, Illinois) in patients with diabetes mellitus. BACKGROUND Randomized, controlled trials have demonstrated comparable clinical outcomes following percutaneous coronary intervention with either Absorb BVS or metallic Xience everolim...

متن کامل

Coronary Artery Vessel Healing Pattern, Short and Long Term, After Implantation of the Everolimus‐Eluting Bioresorbable Vascular Scaffold

BACKGROUND Although the Absorb bioresorbable vascular scaffold is increasingly used in daily clinical practice for the treatment of coronary artery disease, the exact vascular healing pattern and the resorption process in humans is unknown because histological data are derived only from animal studies. METHODS AND RESULTS We have obtained 4 autopsies (5 scaffolds) since August 2013. Duration ...

متن کامل

Recurrent Neoatherosclerosis After Bioresorbable Vascular Scaffold Treatment of In-Stent Restenosis.

A 66-year-old manpresentedanon–ST-segment elevation myocardial infarction 3 years after the implantation of an everolimuseluting stent (3.5 12 mm) in the proximal segment of a saphenous vein graft to a marginal branch. Coronary angiography showed focal in-stent restenosis (ISR) and optical coherence tomography (OCT) confirmed severe ISR (minimal lumen area 3.1 mm). Notably, the tissue causing I...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 12  شماره 

صفحات  -

تاریخ انتشار 2017